Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gulfo Might Reevaluate Negotiated User Fees If Selected US FDA Commish

Executive Summary

Joseph Gulfo, a former medtech industry CEO and vocal FDA critic, is the latest candidate apparently being considered for FDA commissioner. In an interview with Medtech Insight, he outlines his worldview and interest in pushing aggressively against increasing the FDA "body of law."

You may also be interested in...



Obamacare Repeal May Be Delaying User-Fee Bills, Rep. DeGette Says

The House Energy and Commerce Committee Democrat says few in-depth member talks about user-fee bills have taken place because of a focus on Affordable Care Act repeal and replacement.

Trump Meets With Two US FDA Commissioner Candidates; Third Still Lurking

O'Neill and Srinivasan head to Trump Tower, but Gottlieb has not been eliminated.

MDUFA IV Takes Shape: A Catalogue Of Draft Commitments

More specific details have emerged about the agreement "in principle" announced last week by FDA and industry negotiators on the next round of the medical device user-fee program, which will extend from fiscal years 2018 through 2022.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT104364

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel